logo Recombinant Technologies
  • HOME
  • TECHNOLOGY
    • What Is AmyTrap
    • AmyTrap in Action
    • Current Pipeline
  • ABOUT US
    • Leadership
    • Scientific Advisory Board
    • Board of Directors
    • Partnerships
    • Funding
    • Collaborators
  • NEWS
    • Cure for Alzheimer's Disease
    • Publications
  • CONTACT

Colloborators

  • Home
  •  
  • About Us

Yale University

Dr. Caroline Zeiss, DVM, PhD

Dr. Caroline Zeiss is a Professor of Comparative Medicine and Associate Professor of Ophthalmology at the Yale University School of Medicine. She is also Unit Chief of Pathology and is a veterinary anatomic pathologist with expertise in rodent pathology, neuropathology and comparative ocular pathology.

Her research interests include mechanisms of photoreceptor degeneration, rodent models of age-related macular degeneration, Neuroanatomy of age-related gait disorders and Signal transduction events during neuronal death. Dr. Zeiss has been and will be performing histopathological evaluation and provide her expert opinion.

  • What is AmyTrap

    To Know details

  • AmyTrap in Action

    To Know details

  • Current Pipeline

    To Know details

We are Here

RTL's current focus is on developing small molecules to treat Alzheimer's disease.

    Recombinant Technologies, LLC

    1090, Meriden Waterbury Road, Suite1

    06410, USA

    Tel: + (203) 271-3125, Fax: + (203) 271-3126

    E-mail: contact@recombtech.com


Related Publications

  • Sundaram RK, Kasinathan C, Stein S, Sundaram P.Detoxification depots for beta amyloid Readmore
  • Plasma lipids and lipoprotein profile in coronary heart disease and in healthy volunteers in South India. Readmore
  • Novel detox gel depot sequesters β- Amyloid Peptides in a mouse model of Alzheimer's disease. Readmore
  • Patents on potential drugs to treat Alzheimer's Disease: Special emphasis on small peptides. Readmore

Related Links

  • http://www.alzforum.org/ Click Here

  • More News From Nice's Preclinical, Genetics, and Basic Science Fronts Click here

  • Heavyweights Fend Off Dementia; Featherweights Go Down Click Here.

  • FDA Offers Support for Alzheimer's and Parkinson's Biomarkers Click Here

Copyright 2014-2016 Recombinant Technologies | All Rights Reserved | Powered by i-Grandee Software Technologies Pvt.Ltd
Top